Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro (2024)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2023.105766
Publication URI: http://dx.doi.org/10.1016/j.antiviral.2023.105766
Type: Journal Article/Review
Parent Publication: Antiviral Research